HELP     Sign In
Search

Relevance to Autism

Genetic association has been found between the PRKCB1 gene and autism in the AGRE cohort (Philippi et al., 2005). However, no association was found between PRKCB1 and autism in the Irish population.

Molecular Function

Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase has been reported to be involved in many different cellular functions, such as B cell activation, apoptosis induction, endothelial cell proliferation, and intestinal sugar absorption. Studies in mice also suggest that this kinase may also regulate neuronal functions and correlate fear-induced conflict behavior after stress.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism.
ASD
Positive Association
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
SCZ
Negative Association
Protein kinase C-beta 1 gene variants are not associated with autism in the Irish population.
ASD
Support
Mutational Landscape of Autism Spectrum Disorder Brain Tissue
ASD
Support
The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing
ASD
Support
Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.
ASD
Highly Cited
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix compon...
Recent Recommendation
Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN201R001 
 missense_variant 
 c.1748G>A 
 p.Arg583His 
 De novo 
  
 Simplex 
 GEN201R002 
 missense_variant 
 c.473G>A 
 p.Arg158His 
 De novo 
  
  
 GEN201R003 
 3_prime_UTR_variant 
 c.*5171C>T 
  
 Unknown 
  
  

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN201C001 
 intron_variant 
 rs2878156 
 c.205+54736C>T 
  
 AGRE 
 Discovery 
 GEN201C002 
 intron_variant 
 rs3785392 
 c.206-55346A>G 
  
 AGRE 
 Discovery 
 GEN201C003 
 intron_variant 
 rs196002 
 c.206-36592A>G 
  
 AGRE 
 Discovery 
 GEN201C004 
 intergenic_variant 
 rs198160 
 G>T 
  
 40,675 SCZ cases and 64,643 controls (CLOZUK and independent PGC datasets) 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
16
Deletion-Duplication
 20
 
16
Duplication
 4
 
16
Duplication
 15
 
16
Duplication
 1
 

Model Summary

PKC-betaI and PKC-betaII play an important role in B cell activation and may be functionally linked to Bruton's tyrosine kinase in antigen receptor-mediated signal transduction.

References

Type
Title
Author, Year
Primary
Immunodeficiency in protein kinase cbeta-deficient mice.

M_PRKCB_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Insertion of a lacZ-neo cassette into the second exon of the PKC- gene by homologous recombination.
Allele Type: Targeted (Knock Out)
Strain of Origin: 129/Sv
Genetic Background: Not Specified
ES Cell Line: Not Specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_PRKCB_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Adaptive immune response: b cells1
Decreased
Description: Decreased frequency and absolute number of cd23- immunoglobulin m+ (igm+) (b-1) b lymphocytes, cd5+ igm+ (b-1a), and splenic b cells
Exp Paradigm: Three color flow cytometry analysis in peritoneal cavity
 Flow cytometric analysis
 Unreported
Adaptive immune response: b cells antibody production1
Decreased
Description: Decreased levels of igm and igg3 titers
Exp Paradigm: Elisa analysis
 Elisa
 2-3 months
Adaptive immune response: b cells antibody production1
Decreased
Description: Absence of humoral immune response to np-ficoll; decreased primary antibody response to hapten (np) and carrier (cg) antigen
Exp Paradigm: Immunoblot analysis after immunization with t cell-dependent and independent stimulation
 Western blot
 2-3 months
Adaptive immune response: b cells1
Decreased
Description: Decreased proliferation of b cells in response to stimulation with antibody to igm
Exp Paradigm: Macs bs column seperation followed by protein immunoblot analysis
 Western blot
 Unreported
Adaptive immune response: b cells1
 No change
 Flow cytometric analysis
 Unreported
Adaptive immune response: b cells1
 No change
 Western blot
 Unreported
Adaptive immune response: b cells antibody production1
 No change
 Western blot
 2-3 months
Adaptive immune response: t cells1
 No change
 Flow cytometric analysis
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ANXA2 annexin A2 302 P07355 in vitro kinase assay
Jost M and Gerke V 1996
C5AR1 complement component 5a receptor 1 728 P21730 in vitro kinase assay; in vivo kinase assay
Pollok-Kopp B , et al. 2006
CARD11 caspase recruitment domain family, member 11 108723 Q8CIS0 IP/WB; GST; in vivo kinase assay; in vitro kinase assay
Sommer K , et al. 2005
CHAT choline O-acetyltransferase 1103 P28329 in vitro kinase assay
Dobransky T , et al. 2004
GRM5 glutamate receptor, metabotropic 5 24418 P31424 in vitro kinase assay; 2-D phosphopeptide mapping
Kim CH , et al. 2005
HIST1H3A histone cluster 1, H3a 8350 P68431 in vitro kinase assay; in vivo kinase assay
Metzger E , et al. 2010
IFNAR2 interferon (alpha, beta and omega) receptor 2 3455 P48551 IP/WB
Du Z , et al. 2005
IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma 8517 Q9Y6K9 Protein microarray
Fenner BJ , et al. 2010
ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 3689 P05107 in vitro kinase assay; MS
Fagerholm S , et al. 2001
LMNB1 lamin B1 4001 P20700 in vitro kinase assay
Goss VL , et al. 1994
NUMB numb homolog (Drosophila) 8650 P49757 in vitro kinase assay
Smith CA , et al. 2007
PEBP1 phosphatidylethanolamine binding protein 1 5037 P30086 in vitro kinase assay
Corbit KC , et al. 2003
PRKCA protein kinase C, alpha 5578 P17252 IP; LC-MS/MS
Huttlin EL , et al. 2015
PTPN11 protein tyrosine phosphatase, non-receptor type 11 5781 Q06124 in vivo kinase assay
Strack V , et al. 2002
RGS2 regulator of G-protein signaling 2, 24kDa 5997 P41220 in vitro kinase assay
Cunningham ML , et al. 2000
TIAM1 T-cell lymphoma invasion and metastasis 1 21844 Q60610 in vitro kinase assay
Fleming IN , et al. 1999
TRPC3 transient receptor potential cation channel, subfamily C, member 3 22065 Q9QZC1 IP/WB; GST
Numaga T , et al. 2010
YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 7532 P61981 IP/WB
Autieri MV and Carbone CJ 1999
BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) 659 Q13873 GST; MS; Nickel-agarose pull-down
Hassel S , et al. 2004
BTK Bruton agammaglobulinemia tyrosine kinase 12229 P35991 GST; Overlay binding assay; IP/WB; in vitro kinase assay
Yao L , et al. 1994
FMR1 fragile X mental retardation 1 14265 P35922 HITS-CLIP
Darnell JC , et al. 2011
GRIN1 glutamate receptor, ionotropic, NMDA1 (zeta 1) 14810 P35438 Affinity chromatography; IP/WB
Husi H , et al. 2000
GRIN2B glutamate receptor, ionotropic, NMDA2B (epsilon 2) 14812 Q01097 Peptide affinity chromatography
Husi H , et al. 2000
GRK5 G protein-coupled receptor kinase 5 2869 P34947 in vitro kinase assay
Krasel C , et al. 2000
SHC1 src homology 2 domain-containing transforming protein C1 20416 P98083 in vivo kinase assay
Pinton P , et al. 2007
DNM1 dynamin 1 1759 Q05193 GST
Rodriguez MM , et al. 1999
GABRB1 gamma-aminobutyric acid (GABA) A receptor, subunit beta 1 14400 P50571 in vitro kinase assay; GST; Overlay binding assay
Brandon NJ , et al. 1999
GSK3B glycogen synthase kinase 3 beta 84027 P18266 in vitro kinase assay
Goode N , et al. 1992
HMGB1 high-mobility group box 1 25459 P63159 in vitro kinase assay
Xiao DM , et al. 2000
NRGN neurogranin 64356 Q04940 in vitro kinase assay
Huang KP , et al. 1993
PRKCB protein kinase C, beta 25023 P68403 in vitro kinase assay
Kikkawa U , et al. 1982
SLC6A3 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 24898 P23977 IP/WB
Johnson LA , et al. 2005
SPTB spectrin, beta, erythrocytic 6710 P11277 GST
Rodriguez MM , et al. 1999
STXBP1 syntaxin binding protein 1 25558 P61765 in vitro kinase assay
Fujita Y , et al. 1996
AFAP1 actin filament associated protein 1 60312 Q8N556 GST
Qian Y , et al. 2002
GAP43 growth associated protein 43 29423 P07936 in vitro kinase assay
Sheu FS , et al. 1990
TOP2A topoisomerase (DNA) II alpha 170kDa 7153 P11388 in vitro kinase assay; 2-D phosphopeptide mapping
Wells NJ , et al. 1995

HELP
Copyright © 2017 MindSpec, Inc.